Key result
Severe structural valve deterioration occurred in 5.9% of patients overall, but was more frequent with balloon-expandable than self-expanding valves.
Why the study?
With expansion of TAVI into younger patients, valve durability is critically important.
Does valve type (self-expanding vs balloon-expandable) affect long-term structural valve deterioration in patients undergoing TAVI?
Cohort (n=221)
Yes
Does valve type (self-expanding vs balloon-expandable) affect long-term structural valve deterioration in patients undergoing TAVI?
Transcatheter heart valves demonstrate stable hemodynamic function up to 10 years post-procedure, with severe structural valve deterioration occurring in 5.9% of patients, more commonly in those with balloon-expandable valves.
Answers are grounded in this paper and cite their sources.
Severe SVD may differ by valve type after TAVI; leaves open durability questions requiring randomized confirmation before practice change.
BACKGROUND: With expansion of transcatheter aortic valve implantation (TAVI) into younger patients, valve durability is critically important. AIMS: We aimed to evaluate long-term valve function and incidence of severe structural valve deterioration (SVD) among patients ≥ 10-years post-TAVI and with echocardiographic follow-up at least 5-years postprocedure. METHODS: Data on patients who underwent TAVI from 2007 to 2011 were obtained from the UK TAVI registry. Patients with paired echocardiograms postprocedure and ≥5-years post-TAVI were included. Severe SVD was determined according to European task force guidelines. RESULTS: 221 patients (79.4 ± 7.3 years; 53% male) were included with median echocardiographic follow-up 7.0 years (range 5-13 years). Follow-up exceeded 10 years in 43 patients (19.5%). Valve types were the supra-annular self-expanding CoreValve (SEV; n = 143, 67%), balloon-expandable SAPIEN/XT (BEV; n = 67, 31%), Portico (n = 4, 5%) and unknown (n = 7, 3%). There was no difference between postprocedure and follow-up peak gradient in the overall cohort (19.3 vs. 18.4 mmHg; p = NS) or in those with ≥10-years follow-up (21.1 vs. 21.1 mmHg; p = NS). Severe SVD occurred in 13 patients (5.9%; median 7.8-years post-TAVI). Three cases (23.1%) were due to regurgitation and 10 (76.9%) to stenosis. Valve-related reintervention/death occurred in 5 patients (2.3%). Severe SVD was more frequent with BEV than SEV (11.9% vs. 3.5%; p = 0.02), driven by a difference in patients treated with small valves (BEV 28.6% vs. SEV 3.0%; p < 0.01). CONCLUSIONS: Hemodynamic function of transcatheter heart valves remains stable up to more than 10 years post-TAVI. Severe SVD occurred in 5.9%, and valve-related death/reintervention in 2.3%. Severe SVD was more common with BEV than SEV.
No takes yet. Share an insight, caveat, or question.
Ali et al. (2023) conducted a cohort in Transcatheter aortic valve implantation (TAVI) (n=221). Balloon-expandable valves (BEV) vs. Self-expanding valves (SEV) was evaluated on Severe structural valve deterioration (SVD) (p=0.02). Severe structural valve deterioration occurred in 5.9% of patients overall, but was more frequent with balloon-expandable than self-expanding valves.
Synapse has enriched 10 related papers. Consider them for comparative context: